298 related articles for article (PubMed ID: 11481398)
1. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis.
Kaplan M; Hayek T; Raz A; Coleman R; Dornfeld L; Vaya J; Aviram M
J Nutr; 2001 Aug; 131(8):2082-9. PubMed ID: 11481398
[TBL] [Abstract][Full Text] [Related]
2. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice.
Aviram M; Dornfeld L; Rosenblat M; Volkova N; Kaplan M; Coleman R; Hayek T; Presser D; Fuhrman B
Am J Clin Nutr; 2000 May; 71(5):1062-76. PubMed ID: 10799367
[TBL] [Abstract][Full Text] [Related]
3. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins.
Aviram M; Volkova N; Coleman R; Dreher M; Reddy MK; Ferreira D; Rosenblat M
J Agric Food Chem; 2008 Feb; 56(3):1148-57. PubMed ID: 18173244
[TBL] [Abstract][Full Text] [Related]
4. Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it.
Rozenberg O; Howell A; Aviram M
Atherosclerosis; 2006 Sep; 188(1):68-76. PubMed ID: 16332370
[TBL] [Abstract][Full Text] [Related]
5. Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2.
Rosenblat M; Volkova N; Aviram M
Atherosclerosis; 2010 Sep; 212(1):86-92. PubMed ID: 20537330
[TBL] [Abstract][Full Text] [Related]
6. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis.
Hayek T; Kaplan M; Raz A; Keidar S; Coleman R; Aviram M
Atherosclerosis; 2002 Mar; 161(1):65-74. PubMed ID: 11882318
[TBL] [Abstract][Full Text] [Related]
7. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice.
Shamir R; Shehadeh N; Rosenblat M; Eshach-Adiv O; Coleman R; Kaplan M; Hamoud S; Lischinsky S; Hayek T
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):104-10. PubMed ID: 12524232
[TBL] [Abstract][Full Text] [Related]
8. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice.
Rosenblat M; Coleman R; Aviram M
Atherosclerosis; 2002 Jul; 163(1):17-28. PubMed ID: 12048118
[TBL] [Abstract][Full Text] [Related]
9. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation.
Aviram M; Rosenblat M; Gaitini D; Nitecki S; Hoffman A; Dornfeld L; Volkova N; Presser D; Attias J; Liker H; Hayek T
Clin Nutr; 2004 Jun; 23(3):423-33. PubMed ID: 15158307
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase.
Fuhrman B; Volkova N; Aviram M
Atherosclerosis; 2002 Apr; 161(2):307-16. PubMed ID: 11888513
[TBL] [Abstract][Full Text] [Related]
11. Paraoxsonase2 (PON2) and oxidative stress involvement in pomegranate juice protection against cigarette smoke-induced macrophage cholesterol accumulation.
Rom O; Aviram M
Chem Biol Interact; 2016 Nov; 259(Pt B):394-400. PubMed ID: 27163848
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
[TBL] [Abstract][Full Text] [Related]
13. Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice.
Rosenblat M; Volkova N; Coleman R; Aviram M
Atherosclerosis; 2007 Dec; 195(2):e61-8. PubMed ID: 17588583
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.
Rozenberg O; Shih DM; Aviram M
Atherosclerosis; 2005 Jul; 181(1):9-18. PubMed ID: 15939049
[TBL] [Abstract][Full Text] [Related]
15. Anti-atherogenic properties of date vs. pomegranate polyphenols: the benefits of the combination.
Rosenblat M; Volkova N; Borochov-Neori H; Judeinstein S; Aviram M
Food Funct; 2015 May; 6(5):1496-509. PubMed ID: 25811166
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.
Rosenblat M; Hayek T; Aviram M
Atherosclerosis; 2006 Aug; 187(2):363-71. PubMed ID: 16226266
[TBL] [Abstract][Full Text] [Related]
17. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity.
Fuhrman B; Volkova N; Coleman R; Aviram M
J Nutr; 2005 Apr; 135(4):722-8. PubMed ID: 15795424
[TBL] [Abstract][Full Text] [Related]
18. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages.
Fuhrman B; Volkova N; Aviram M
J Nutr Biochem; 2005 Sep; 16(9):570-6. PubMed ID: 16115546
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein.
Rosenblat M; Volkova N; Coleman R; Aviram M
J Agric Food Chem; 2006 Mar; 54(5):1928-35. PubMed ID: 16506855
[TBL] [Abstract][Full Text] [Related]
20. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice.
Keidar S; Hayek T; Kaplan M; Pavlotzky E; Hamoud S; Coleman R; Aviram M
J Cardiovasc Pharmacol; 2003 Jun; 41(6):955-63. PubMed ID: 12775976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
